Vesicare Tablets / Film-coated
Solifenacin Succinate
10mg
Saudi Arabian Japanese Pharmaceutical Co. Ltd (SAJA)
| Pack size | 30's (10's Blister x 3) |
|---|---|
| Dispensing mode | POM |
| Source | SAUDI ARABIA |
| Agent | CITY MEDICAL STORE |
| Retail Price | 203.00 AED |
Available as:
Indications
Vesicare Tablets / Film-coated is used for:
Overactive bladder
Adult Dose
Oral
Overactive bladder
Adult: 5 mg once daily. If well tolerated, may increase to 10 mg once daily if needed. For patients who are concurrently taking CYP3A4 inhibitors (e.g. ketoconazole, ritonavir): Max dose: 5 mg once daily.
Hepatic impairment: Child-pugh class B: Max: 5 mg daily; Child-pugh class C: Use is not recommended.
Child Dose
Renal Dose
Renal impairment:
CrCl (ml/min) Dosage Recommendation
<30 Max: 5 mg daily.
Administration
May be taken with or without food. Swallow whole, do not chew/crush.
Contra Indications
Uncontrolled narrow-angle glaucoma, urinary retention, gastric retention.
Precautions
Increased risk of urinary retention in patients with bladder outflow obstruction. Caution in patients with decreased GI motility, GI obstructive diseases, controlled narrow-angle glaucoma, liver or kidney impairment, patients with known history of QT prolongation or other risk factors for QT prolongation. May cause drowsiness and/or blurred vision. Monitor serum creatinine clearance and liver function. Maintain adequate hydration. Increased susceptibility to heat prostration due to reduced ability to sweat. Pregnancy, lactation.
Pregnancy-Lactation
Interactions
May interfere with the prokinetic effects of cisapride and metoclopramide.
Potentially Fatal: May reduce the stimulatory effect of secretin. Concurrent use with biperiden, orphenadrine, procyclidine or trihexyphenidyl may cause anticholinergic effects such as confusion and loss of bladder control; a washout period of 1 wk between using these drugs is recommended. May increase the ulcerogenic effect of potassium chloride.
Strong CYP3A4 inhibitors (e.g. ketoconazole, fluconazole, itraconazole, erythromycin, telithromycin, clarithromycin, ritonavir, indinavir, nelfinavir, nefazodone, aprepitant, verapamil) may reduce the metabolism of solifenacin, thus increasing its plasma levels.
Adverse Effects
Side effects of Solifenacin Succinate :
Constipation, dyspepsia, nausea, upper abdominal pain, xerostomia, hypertension, oedema, headache, depression, fatigue, urinary tract infection, blurred vision, cough, influenza.
Mechanism of Action
Solifenacin is a selective M3 antimuscarinic that inhibits muscarinic receptors resulting in decreased urinary bladder contraction, increased residual urine volume and decreased detrusor muscle pressure.
Note
Vesicare 10mg Tablets / Film-coated manufactured by Saudi Arabian Japanese Pharmaceutical Co. Ltd (SAJA). Its generic name is Solifenacin Succinate. Vesicare is availble in United Arab Emirates.
Farmaco UAE drug index information on Vesicare Tablets / Film-coated is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Solifenacin Succinate :
Tablets / Film-coated
Vesilife
5mg
Lifepharma FZE
Tablets / Film-coated
Vesilife
10mg
Lifepharma FZE
Tablets / Film-coated
Urilax
10mg
Tabuk Pharmaceutical Manufacturing Co.
Tablets / Film-coated
Urilax
5mg
Tabuk Pharmaceutical Manufacturing Co.
Tablets / Film-coated
Urinacin
10mg
Pharmax Pharmaceuticals FZ LLC